Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, CDT Capital Management. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
YTD+7.05%
Annualized+22.5%
Positioning StanceCONSTRUCTIVE
GeographyUS
Digest Analysis
Quick Take
"The fund aggressively deployed cash reserves from 19% down to 8.1%, initiating positions in custom silicon enablers like Broadcom and insider-bought names while retaining an overweight in healthcare."
Executive Summary
CDT Capital Management navigates market environments through a disciplined focus on capital allocation and valuation dynamics, positing that surging interest rates and historic capital expenditures are reshaping equity risk-reward profiles. During September 2026, the strategy fell -6.25% net of fees against a -0.35% decline for the S&P 500, amidst a broader sector-level drawdown where the median index sector dropped 5.74%. The manager attributes broader market fragility to rising cost of capital, with the 10-year Treasury yield surpassing 5% and the Federal Reserve increasing interest rates by 25 basis points to a 3.75%-4.00% range. Macroeconomic risks remain elevated due to unsustainable capital spending cycles in artificial intelligence that approach historic bubble levels relative to gross domestic product. In response, the fund leveraged its cash reserves—reducing cash balances from roughly 19% to 8.1%—to deploy capital into selective equities showing strong corporate insider buying, while revamping its artificial intelligence thesis to favor custom application-specific chip enablers and hyperscalers over dominant generalist chip suppliers.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
68%
CautiousHigh
Moderate (68%)
CDT demonstrates solid conviction by deploying substantial cash into a targeted list of new positions and establishing Broadcom as one of its largest holdings. However, conviction is tempered by broad sector diversification across eight newly added names and an acknowledged willingness to evolve previous macro theses. The manager also maintains a structural overweight in healthcare rather than concentrating entirely on a single high-conviction bet.
Growth Outlook
38%
BearishBullish
Neutral (38%)
The manager expresses caution regarding broader equity markets, emphasizing that equity risk is expensive with the S&P 500 excess earnings yield at -1.84% and long-term interest rates surpassing 5%. While technology headline indices held up, median sectors suffered steep declines of 5.74%, highlighting fundamental fragility. Directional optimism is focused strictly on tactical insider-bought names and custom silicon beneficiaries rather than broad market indices.
Risk Appetite
72%
DefensiveAggressive
Aggressive (72%)
Risk appetite shifted decidedly toward risk-seeking deployment as the fund reduced its cash reserves from 18.7% in August to 8.1% in September. Capital was aggressively allocated into eight new equity holdings across retail, aerospace, software, and tech. Despite acknowledging macro headwinds, the portfolio's net long positioning expanded meaningfully during the drawdown.
Capital Deployment
95%
De-riskingDeploying
Deploying (95%)
The fund engaged in aggressive capital deployment, slashing cash reserve balances from 18.7% down to 8.1% within the month. This exceeds the threshold for aggressive deployment (>5% cash reduction) as capital was poured into Broadcom, Oracle, Microsoft, and five other newly initiated holdings. The manager moved decisively from capital preservation to active risk acquisition.
Forward Guidance
75%
CautiousExpansionary
Expansionary (75%)
Forward guidance reflects an active bias toward continuing selective deployments, particularly into custom silicon partners, hyperscalers, and structural healthcare compounders. The manager explicitly executed repurchases of Microsoft and initiated Oracle while targeting further artificial intelligence infrastructure participants. There is no indication of hedging or defensive cash accumulation in the near term.
Language Signal
46%
BearishBullish
Balanced (46%)
The text balances stark warnings of historic capital bubbles, untenable vendor profit extraction, and rising cost of capital against optimistic language around transformative technologies and insider buying opportunities. Negative terminology like 'nasty drawdown,' 'feeding frenzy,' and 'renting profits' offsets constructive terms like 'transformative force' and 'auspicious positioning.' This results in an approximately neutral net language signal.
Perceived Risk
78%
Low RiskElevated
Elevated Risk (78%)
The manager perceives macroeconomic and systemic risks to be elevated, calling attention to long-term Treasury yields above 5% and central bank rate increases. The letter explicitly compares current artificial intelligence capex trajectories to the Railroad Bubble of the 1870s and the early 2000s Housing Market Boom. Additionally, customer cash burn and an S&P 500 excess earnings yield of -1.84% are framed as serious environmental risks.
Opportunity Density
68%
ScarceAbundant
Abundant (68%)
The manager views the current opportunity set as selectively rich following the sector-level market drawdown. A sharp rise in corporate insider sentiment revealed attractive entry points across diverse sectors including medical devices, aerospace, software, and retail. Furthermore, a newly adopted analytical framework for AI custom silicon unlocked high-conviction ideas like Broadcom.
Time Horizon
74%
Short-TermLong-Term
Decade+ (74%)
The manager operates with a multi-year investment horizon spanning through 2028 to 2030, referencing long-range hyperscaler capex cycles and structural demographic trends underpinning the healthcare allocation. The thesis surrounding in-house silicon adoption displacing merchant chip providers is explicitly framed as playing out over several years. Short-term performance noise is subordinated to secular compounding.